Predicting outcomes in acute coronary syndrome using biochemical markers

Area of Science:

• Cardiology
• Biomarkers
• Renal Medicine

Background:

• Acute coronary syndrome (ACS) poses a significant mortality risk.
• Effective risk stratification is crucial for managing ACS patients.
• Novel biomarkers and renal function assessments are needed for improved prognostication.

Purpose of the Study:

• To evaluate the predictive value of high-sensitivity C-reactive protein (hs-CRP) and estimated glomerular filtration rate (eGFR) for mortality in ACS patients.
• To assess these markers at different time points: during hospitalization, at 6 weeks, and at 6 months post-event.

Main Methods:

• Prospective observational study enrolling 108 ACS patients.
• Primary outcome: all-cause mortality.
• hs-CRP levels and eGFR (using MDRD formula) measured at admission, 6 weeks, and 6 months.

Main Results:

• hs-CRP >5mg/dl strongly predicted mortality during hospital stay and at 6 weeks (p<0.001).
• In-hospital mortality was 11% and overall 6-month mortality was 28% (p<0.001).
• Low eGFR (median 45ml/min/1.73m²) at admission was statistically significant for mortality risk.

Conclusions:

• Elevated hs-CRP (>5mg/dl) and low eGFR (≤30ml/min/1.73m²) are significant predictors of mortality in ACS.
• These simple assessments may aid in predicting ACS outcomes, especially in resource-poor settings.
• Further validation is recommended for these potential prognostic tools.